This peer-reviewed case report documents the effects of Extracorporeal Blood Oxygenation and Ozonation (EBOO) on urinary toxin excretion in an 88-year-old female with long-standing iron-deficiency anemia and documented exposure to mycotoxins, heavy metals, and environmental toxins.
The patient underwent two series of EBOO treatments, each consisting of three sequential procedures, designed to circulate and treat nearly the full blood volume through an ex vivo oxygen–ozone filtration system. Urinary toxin levels were measured at baseline, after the first EBOO series, and after the second series.
Key Findings
- Substantial toxin reductions were observed across multiple categories:
- Mycotoxins: average reduction of 64.8%
- Environmental toxins: average reduction of 55.1%
- Heavy metals: average reduction of 25.7%
- Nearly all measured toxins declined from baseline to study completion, with the exception of nickel, which increased—likely due to re-exposure or mobilization rather than treatment-related contamination.
- Hemoglobin levels remained largely unchanged, fluctuating within a narrow range, indicating that toxin reduction did not translate into immediate hematologic correction.
- Despite stable hemoglobin, the patient reported subjective improvements in well-being following the first EBOO series.
Clinical Significance
The report highlights the difficulty of removing chronic environmental toxins using conventional therapies, particularly when exposure is ongoing. Existing interventions—such as chelation or dietary avoidance—are often limited in scope or applicability. In contrast, EBOO demonstrated the ability to reduce multiple toxin classes in a real-world clinical setting simultaneously.
While the exact mechanisms remain unclear, the authors propose that ex vivo ozonation may stimulate endogenous detoxification pathways, potentially through transient oxidative signaling and immune modulation. Importantly, this case represents one of the first documented human reports measuring toxin levels before and after EBOO treatment.
Limitations and Future Directions
- Single-patient case report with no control group
- Ongoing environmental exposure could not be fully controlled
- Hematologic outcomes did not significantly improve during the study window
The authors emphasize the need for larger, controlled studies to determine causality, durability of toxin reduction, and clinical relevance for chronic conditions such as anemia.
Conclusion
This case suggests that EBOO may serve as a promising adjunctive therapy for systemic toxin burden, particularly in patients with chronic environmental exposure. While not shown to directly correct anemia in this case, the significant reduction in toxins supports further investigation into EBOO’s role in integrative and regenerative medicine.
Source:
Bennett SJ, Kuo J, Wang S, Salway RJ. Observed Reduction in Urinary Toxin Excretion With Extracorporeal Blood Oxygenation and Ozonation (EBOO) Treatment in an 88-Year-Old With Chronic Anemia: A Case Report. Cureus. December 23, 2025.
DOI: 10.7759/cureus.99948
https://doi.org/10.7759/cureus.99948
